Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-05 @ 1:45 PM
Study NCT ID:
NCT06824168
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-02-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Sponsor:
Daiichi Sankyo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-07-14
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-07
First Submit QC Date:
None
Study First Post Date:
2025-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-02
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED